During tumor development, inhibitory immune checkpoint proteins such as PD-L1 are usually overexpressed on cancer cells, causing dysregulation of immune responses which consequently leads to the failure of the immune system to eliminate cancer cells [14,15,16]. Here, CD274 is linked to neoplasm.